The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
Children with AAV and kidney disease face increased risks for long-term renal damage at 1 year, despite the majority achieving inactive renal disease by this time.
Many older people develop chronic kidney disease and are also likely to be on cholesterol-lowering drugs known as statins.
In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).
Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team led by the University of Iowa has found.
Statins, which are prescription drugs that can reduce cholesterol levels and lower the risk for heart disease, don’t affect kidney function, new research shows.
Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team led by the University of ...
Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team led by the University of ...
End-stage renal disease (ESRD) is defined as severe irreversible kidney damage, measured by the level of proteinuria and a reduction in the glomerular filtration rate to ˂15 ml/min/1.73 m2 ...
Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team led by the University of ...
The following is a summary of “Prognostic impact of albuminuria in early-stage chronic kidney disease on cardiovascular outcomes: a cohort study,” published in the January 2025 issue of Cardiology by ...
South Korea: A study of over 1.9 million patients with type 2 diabetes (T2D) found that glomerular hyperfiltration (GHF) was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback